Millennium Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-26,154
| Closed | -$251K | – | 5675 |
|
|
2025
Q4 | $251K | Sell |
26,154
-60,720
| -70% | -$582K | ﹤0.01% | 5356 |
|
|
2025
Q3 | $817K | Sell |
86,874
-46,799
| -35% | -$447K | ﹤0.01% | 4770 |
|
|
2025
Q2 | $1.41M | Buy |
133,673
+56,125
| +72% | +$708K | ﹤0.01% | 4158 |
|
|
2025
Q1 | $1.17M | Buy |
77,548
+52,045
| +204% | +$866K | ﹤0.01% | 4241 |
|
|
2024
Q4 | $420K | Sell |
25,503
-14,006
| -35% | -$276K | ﹤0.01% | 4868 |
|
|
2024
Q3 | $976K | Buy |
39,509
+8,797
| +29% | +$228K | ﹤0.01% | 4300 |
|
|
2024
Q2 | $778K | Sell |
30,712
-85,381
| -74% | -$2.21M | ﹤0.01% | 4287 |
|
|
2024
Q1 | $2.95M | Sell |
116,093
-211,549
| -65% | -$5.12M | ﹤0.01% | 3386 |
|
|
2023
Q4 | $7.42M | Sell |
327,642
-246,897
| -43% | -$5.11M | ﹤0.01% | 2453 |
|
|
2023
Q3 | $10.7M | Buy |
574,539
+443,763
| +339% | +$9.2M | 0.01% | 1989 |
|
|
2023
Q2 | $3.4M | Buy |
130,776
+122,659
| +1,511% | +$3.28M | ﹤0.01% | 3020 |
|
|
2023
Q1 | $233K | Sell |
8,117
-121,844
| -94% | -$3.63M | ﹤0.01% | 5082 |
|
|
2022
Q4 | $3.85M | Buy |
129,961
+120,092
| +1,217% | +$3.42M | ﹤0.01% | 3025 |
|
|
2022
Q3 | $235K | Sell |
9,869
-26,996
| -73% | -$621K | ﹤0.01% | 5545 |
|
|
2022
Q2 | $823K | Buy |
+36,865
| New | +$822K | ﹤0.01% | 4551 |
|
|
2022
Q1 | – | Sell |
-30,325
| Closed | -$1.09M | – | 6864 |
|
|
2021
Q4 | $1.09M | Sell |
30,325
-919
| -3% | -$36.8K | ﹤0.01% | 4334 |
|
|
2021
Q3 | $1.33M | Sell |
31,244
-13,208
| -30% | -$544K | ﹤0.01% | 4368 |
|
|
2021
Q2 | $1.92M | Sell |
44,452
-78,874
| -64% | -$3.36M | ﹤0.01% | 4005 |
|
|
2021
Q1 | $5.03M | Buy |
123,326
+99,036
| +408% | +$3.76M | ﹤0.01% | 2562 |
|
|
2020
Q4 | $1.1M | Buy |
+24,290
| New | +$922K | ﹤0.01% | 3679 |
|
|
2020
Q2 | – | Sell |
-59,236
| Closed | -$1.71M | – | 4141 |
|
|
2020
Q1 | $1.71M | Sell |
59,236
-36,778
| -38% | -$1.49M | ﹤0.01% | 2120 |
|
|
2019
Q4 | $4.98M | Sell |
96,014
-95,947
| -50% | -$5.57M | 0.01% | 1946 |
|
|
2019
Q3 | $10.5M | Sell |
191,961
-96,864
| -34% | -$4.97M | 0.02% | 1248 |
|
|
2019
Q2 | $11.7M | Buy |
288,825
+62,268
| +27% | +$2.27M | 0.02% | 1133 |
|
|
2019
Q1 | $6.85M | Buy |
226,557
+36,009
| +19% | +$1.23M | 0.01% | 1542 |
|
|
2018
Q4 | $6.4M | Buy |
190,548
+99,387
| +109% | +$3.59M | 0.01% | 1417 |
|
|
2018
Q3 | $3.85M | Buy |
91,161
+27,326
| +43% | +$1.08M | ﹤0.01% | 1995 |
|
|
2018
Q2 | $2.04M | Buy |
63,835
+20,420
| +47% | +$841K | ﹤0.01% | 2382 |
|
|
2018
Q1 | $2.16M | Buy |
43,415
+39,554
| +1,024% | +$2.23M | ﹤0.01% | 2263 |
|
|
2017
Q4 | $208K | Sell |
3,861
-3,982
| -51% | -$220K | ﹤0.01% | 3515 |
|
|
2017
Q3 | $455K | Buy |
+7,843
| New | +$410K | ﹤0.01% | 2885 |
|
|
2017
Q2 | – | Sell |
-86,892
| Closed | -$3.77M | – | 3428 |
|
|
2017
Q1 | $3.77M | Buy |
86,892
+50,613
| +140% | +$2.42M | 0.01% | 1618 |
|
|
2016
Q4 | $1.78M | Sell |
36,279
-149,509
| -80% | -$6.91M | ﹤0.01% | 1937 |
|
|
2016
Q3 | $8.89M | Buy |
185,788
+148,166
| +394% | +$7.32M | 0.01% | 997 |
|
|
2016
Q2 | $2.02M | Sell |
37,622
-22,731
| -38% | -$1.07M | ﹤0.01% | 1779 |
|
|
2016
Q1 | $2.7M | Sell |
60,353
-103,956
| -63% | -$4.22M | 0.01% | 1624 |
|
|
2015
Q4 | $6.27M | Sell |
164,309
-71,780
| -30% | -$2.75M | 0.01% | 1212 |
|
|
2015
Q3 | $7.51M | Buy |
236,089
+111,865
| +90% | +$3.9M | 0.01% | 1103 |
|
|
2015
Q2 | $4.1M | Buy |
124,224
+74,224
| +148% | +$2.65M | 0.01% | 1513 |
|
|
2015
Q1 | $2.06M | Sell |
50,000
-120,096
| -71% | -$4.86M | ﹤0.01% | 1924 |
|
|
2014
Q4 | $6.93M | Sell |
170,096
-205,733
| -55% | -$8.04M | 0.01% | 1191 |
|
|
2014
Q3 | $13.8M | Buy |
375,829
+253,405
| +207% | +$11M | 0.03% | 694 |
|
|
2014
Q2 | $5.67M | Buy |
122,424
+25,272
| +26% | +$1.12M | 0.02% | 1135 |
|
|
2014
Q1 | $3.99M | Buy |
97,152
+72,452
| +293% | +$2.69M | 0.01% | 1334 |
|
|
2013
Q4 | $943K | Buy |
24,700
+13,335
| +117% | +$411K | ﹤0.01% | 2331 |
|
|
2013
Q3 | $272K | Sell |
11,365
-1,615
| -12% | -$36.3K | ﹤0.01% | 2922 |
|
|
2013
Q2 | $221K | Buy |
+12,980
| New | +$187K | ﹤0.01% | 2708 |
|
Other funds holding ANIK
CP
VCM
BFM
CM
Millennium Management's ANIK Position: Q1 2026 in Review
Millennium Management sold out of Anika Therapeutics (ANIK) in Q1 2026, closing a stake of 26,154 shares — an estimated $251K sold.
Millennium Management first reported a position in ANIK in Q2 2013 and held it in 47 quarters. The position peaked at $13.8M in Q3 2014. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.
- Millennium Management reported no remaining Anika Therapeutics position as of Q1 2026 after selling out during the quarter.
- Millennium Management sold 26,154 Anika Therapeutics shares in Q1 2026, an estimated $251K.
- Millennium Management first reported a position in Anika Therapeutics in Q2 2013 and held it in 47 quarters.
- Millennium Management's Anika Therapeutics position peaked at $13.8M in Q3 2014.
- 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.